Current Neurology and Neuroscience Reports

, Volume 11, Issue 4, pp 409–417 | Cite as

Prognosis of Intractable Epilepsy: Is Long-Term Seizure Freedom Possible with Medical Management?



Until recently, very little data existed on long-term seizure prognosis of patients with intractable epilepsy. We review recent work that assessed seizure remission in patients with intractable epilepsy during medical management. Recent prevalence cohort studies among adults with longstanding intractable epilepsy have demonstrated notable proportions of patients attaining at least 1-year seizure freedom, ranging from more than 10% to nearly 30% of patients, when followed for mean duration of 18 months to 6 years. Additionally, a recent prospective cohort study of pediatric-onset intractable epilepsy (followed prospectively for seizure outcome from onset of intractability) revealed minimum 1-year seizure remission among more than half of study patients. Despite the notable rates of remission seen among patients with intractable epilepsy, many individuals experienced subsequent seizure relapse. These findings highlight the continued importance of surgical therapy for those who are good candidates and the need for further development of effective therapeutic interventions.


Epilepsy Seizure freedom Remission Relapse Intractable Refractory Drug-resistant Pharmacoresistant Medical treatment Medical management Prognosis Outcome Long-term 


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Kwan P, Brodie M. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Shafer SQ, Hauser WA, Annegers JF, Klass DW. EEG and other early predictors of epilepsy remission: a community study. Epilepsia. 1988;29:590–600.PubMedCrossRefGoogle Scholar
  3. 3.
    Cockerell OC, Johnson AL, Sander JWAS, Shorvon SD. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective, population-based study. Epilepsia. 1997;38:31–46.PubMedCrossRefGoogle Scholar
  4. 4.
    Geerts A, Arts WF, Stroink H, et al. Course and outcome of childhood epilepsy: a 15-year follow-up of the Dutch study of epilepsy in childhood. Epilepsia. 2010;51:1189–97.PubMedCrossRefGoogle Scholar
  5. 5.
    Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain. 2006;129:617–24.PubMedCrossRefGoogle Scholar
  6. 6.
    Sillanpää M, Schmidt D. Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain. 2009;132:989–98.PubMedCrossRefGoogle Scholar
  7. 7.
    Berg AT, Shinnar S, Levy SR, et al. Early development of intractable epilepsy in children: a prospective study. Neurology. 2001;56:1445–52.PubMedGoogle Scholar
  8. 8.
    Camfield P, Camfield C. Long-term prognosis for symptomatic (secondarily) generalized epilepsies: a population-based study. Epilepsia. 2007;48:1128–32.PubMedCrossRefGoogle Scholar
  9. 9.
    Berg AT, Vickrey BG, Testa FM, et al. How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol. 2006;60:73–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Wiebe S, Blume WT, Girvin JP, et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Spencer SS, Berg AT, Vickrey BG, et al. Initial outcomes in the Multicenter Study of Epilepsy Surgery. Neurology. 2003;61:1680–5.PubMedGoogle Scholar
  12. 12.
    Spencer SS, Berg AT, Vickrey BG, et al. Predicting long-term seizure outcome after resective epilepsy surgery: the Multicenter Study. Neurology. 2005;65:912–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Engel J, Wiebe S, French J, et al. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology. 2003;60:538–47.Google Scholar
  14. 14.
    Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable? Neurology. 2003;60:186–90.PubMedGoogle Scholar
  15. 15.
    Huttenlocher PR, Hapke RJ. A follow-up study of intractable seizures in childhood. Ann Neurol. 1990;28:699–705.PubMedCrossRefGoogle Scholar
  16. 16.
    Selwa LM, Schmidt SL, Malow BA, Beydoun A. Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy. Epilepsia. 2003;44:1568–72.PubMedCrossRefGoogle Scholar
  17. 17.
    Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol. 2007;62:375–81.PubMedCrossRefGoogle Scholar
  18. 18.
    Callaghan BC, Anand K, Hesdorffer D, et al. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol. 2007;62:382–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Callaghan B, Schlesinger M, Rodemer W, et al. Remission and relapse in an adult refractory epilepsy population [abstract 1.111]. Presented at the 63rd Annual Meeting of the American Epilepsy Society. Boston, MA; December 4–8, 2009.Google Scholar
  20. 20.
    • Choi H, Heiman G, Pandis D, et al. Seizure remission and relapse in adults with intractable epilepsy: a cohort study. Epilepsia. 2008;49:1440–5. This was a prevalence cohort study of adult patients seen in 2001 at the Columbia Comprehensive Epilepsy Center who had failed more than two AEDs in the past and experienced at least monthly seizures. Patients were followed up for mean 3.9 years, and the annual probability of greater than 1-year seizure remission was about 4% per year, with 18% cumulative probability at 5 years.Google Scholar
  21. 21.
    • Choi H, Heiman GA, Munger Clary H, et al. Seizure remission in adults with long-standing intractable epilepsy: an extended follow-up. Epilepsy Res. 2010, In press. In this follow-up study of the prevalence cohort of adults with intractable epilepsy receiving care at Columbia University, continued remissions were seen over a mean follow-up of 5.9 years. The cumulative rate of remission was about 3% to 4% per year, and most patients (60%) who had greater than 1-year remission subsequently had relapse of seizures. Some patients experienced more than one remission.Google Scholar
  22. 22.
    French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62:1261–73.PubMedGoogle Scholar
  23. 23.
    Gazzola DM, Balcer LJ, French JA. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia. 2007;48:1303–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Zaccara G, Messori A, Cincotta M, Burchini G. Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we learn from long-term studies? Acta Neurol Scand. 2006;114:157–68.PubMedCrossRefGoogle Scholar
  25. 25.
    Lhatoo SD, Sander JWAS, Shorvon SD. The dynamics of drug treatment in epilepsy: an observational study in an unselected population based cohort with newly diagnosed epilepsy followed up prospectively over 11–14 years. J Neurol Neurosurg Psychiatry. 2001;71:632–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Schiller Y, Najjar Y. Quantifying the response to antiepileptic drugs: effect of past treatment history. Neurology. 2008;70:54–65.PubMedCrossRefGoogle Scholar
  27. 27.
    • Berg AT, Levy SR, Testa FM, D’Souza R: Remission of epilepsy after two drug failures in children: a prospective study. Ann Neurol. 2009;65:510–9. This was a prospective incidence cohort of pediatric patients in Connecticut followed up for median of more than 10 years after failure of two appropriate AEDs at maximally tolerated dose, which showed a large percentage of patients eventually experiencing seizure remission (57%). Most of those who had a 1-year seizure remission eventually relapsed, and many patients had multiple remissions and relapses. Idiopathic epilepsy and seizure frequency were shown to be independent predictors of 1-year seizure remission.Google Scholar
  28. 28.
    Takenaka J, Aso K, Watanabe K, et al. Transient seizure remission in intractable localization-related epilepsy. Pediatr Neurol. 2000;23:328–31.PubMedCrossRefGoogle Scholar
  29. 29.
    Spooner CG, Berkovic SF, Mitchell LA, et al. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology. 2006;67:2147–53.PubMedCrossRefGoogle Scholar
  30. 30.
    Shih T, Lowenstein D. Pharmacoresistant epilepsy: if at first you don’t succeed…. Ann Neurol. 2007;62:311–3.PubMedCrossRefGoogle Scholar
  31. 31.
    Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2009;51:1069–77.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Columbia Comprehensive Epilepsy CenterThe Neurological InstituteNew YorkUSA

Personalised recommendations